William Wagner, MD
Ophthalmology · St George, UTNPI 1861053050
Payments from drug & device makers
Across 63 payments — averaging $41.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sight Sciences, Inc.$602
- Alcon$549
- Biotissue Holdings Inc.$275
- Regeneron Healthcare Solutions, Inc.$270
- AbbVie$169
- Alimera Sciences, Inc.$141
- plus $621 from 12 others
What the payments were for
- Food & beverage$2,52696%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sight Sciences, Inc. | 8 | $602 |
| Alcon | 12 | $549 |
| Biotissue Holdings Inc. | 4 | $275 |
| Regeneron Healthcare Solutions, Inc. | 11 | $270 |
| AbbVie(2 entities) | 5 | $169 |
| Alimera Sciences, Inc. | 1 | $141 |
| Glaukos Corporation | 1 | $85 |
| Apellis Pharmaceuticals, Inc. | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $82 |
| Bausch & Lomb Americas Inc. | 3 | $70 |
| LKC Technologies, Inc. | 2 | $66 |
| Astellas Pharma US Inc | 3 | $66 |
| Dompe US, Inc. | 2 | $43 |
| Tarsus Pharmaceuticals, Inc. | 2 | $38 |
| Genentech USA, Inc. | 1 | $26 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $21 |
| Harrow Eye, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$402
- Iluvien$141
- AcrySof$132
- AcrySof IQ VIVITY IOL$127
How this compares
$2,626 in reported general payments places this provider in the 65th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 66 | $2,624 |
| ValacyclovirValacyclovir Hcl | 20 | $1,040 |
| Ketorolac Tromethamine | 20 | $599 |
| Brimonidine Tartrate | 20 | $443 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 29 | $439 |
| Latanoprost | 24 | $378 |
| MoxifloxacinMoxifloxacin Hcl | 22 | $359 |
| Timolol Maleate | 15 | $129 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in St George
- Jason HendrixSt George$582K
- David SladeSt George$167K
- Sharon RichensSt George$36K
- Shawno MaySt George$4K
- Majid MoshirfarSalt Lake City$1.4M
- Iqbal AhmedSalt Lake City$1.1M
- Zachary ZavodniSalt Lake City$1.1M
- Mark BallifOgden$486K
- Benjamin DastrupSouth Ogden$378K
- Paul BernsteinSalt Lake City$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.